Taken together, these data show that transgenic expression of LIN28A in erythroblasts from pediatric subjects with sickle cell anemia regulates both fetal and beta (sickle)-globin expression with comparable ex vivo differentiation of the cells. The gene discussed is LIN28A; the disease is sickle cell disease.